Goran Micevic

Goran Micevic is an Assistant Professor at Yale School of Medicine and Yale Cancer Center, leading a research group focused on melanoma immunobiology and inflammatory skin diseases. His work bridges epigenetic mechanisms with immune response regulation in cutaneous malignancies.

• Board-certified in Dermatology and Dermatopathology (2024)
• Affiliated with Molecular Medicine, Pharmacology, and Physiology Program
• Member of Janeway Society and Hamburg House Affiliates

Research interests include:

• Epigenetic regulation in melanoma formation
• Immune checkpoint modulators (PD-1/PD-L1)
• Epigenetics-Immunology crosstalk
• Prognostic methylation signatures
• T-cell exhaustion in melanoma
• Therapeutic targeting of DNMT3B

Clinical interests span cutaneous malignancies, atopic dermatitis, alopecia areata, and psoriasis. His lab employs mouse models, single-cell sequencing, and CRISPR technology to explore next-generation cancer immunotherapies.

Scientific awards include:

• Dermatology Foundation Career Development Award (2023)
• Ruth L. Kirschstein Fellowship (2019)
• Yale's Selma & Karl Folkers Prize (2018)
• Milton Winternitz Prize (2018)

Students include co-mentored graduate researcher Maya Deshmukh. Recent grants include support from the Skin Cancer Foundation (2023) for epigenetic immunotherapy research.